FDA Fertility and Maternal Health Drugs Advisory Committee
Executive Summary
Oral contraceptives patient package insert improvement proposal will be discussed Feb. 8 at FDA's Parklawn facility in conference rooms D & E. The meeting convenes at 9 a.m.